Neuro COVID is a subcategory of post COVID complications affecting the brain and nervous system. Antibody studies show this occurs in about 40% of those experiencing post viral syndrome.

It appears the newest COVID-19 variants have the ability to slip by the antibody response people have built from prior infections and the vaccination. This means everyone is vulnerable, and the risks of neuro COVID, organ failure, hospitalizations, and death are higher.

A report released by New York State Insurance Fund found that 31% of workers who filed claims for COVID-19 continued medical treatment or took time off work more than 60 days after the initial infection. This article provides insights into the demographics of those affected and the claims outcomes.

It is well documented that inflammation plays a significant role in Post COVID Condition (PCC), aka Long COVID. This article offers insights as to how neuro COVID develops by detailing the pathophysiology in the brain that correlates with post COVID depressive and cognitive symptoms, including slowed motor speed, low motivation or energy, and anhedonia, after initially mild to moderate COVID-19 illness. This information validates the need for early identification of new (acute) infections and post-acute phases to prevent or minimize the risks associated with long term damage that can occur when neural inflammation is left untreated.